Principles, Method Selection, and Result Interpretation for Malondialdehyde Content Detection
Principles, Method Selection, and Result Interpretation for Malondialdehyde Content Detection
Malondialdehyde (MDA) is an important small-molecule aldehyde product formed during lipid peroxidation. It is commonly used to evaluate oxidative stress and membrane lipid oxidative damage in cells, tissues, or body-fluid samples. The key to MDA detection is not only obtaining absorbance or fluorescence values, but also interpreting the results together with sample type, detection method, reaction specificity, and normalization strategy.
Keywords: malondialdehyde; MDA; lipid peroxidation; oxidative stress; TBA method; TBARS; thiobarbituric acid; HPLC; 4-HNE; SOD; CAT; GSH-Px
1 Biological Significance of Malondialdehyde
1.1 Product of Lipid Peroxidation
(1) Formation mechanism
Cell membranes are rich in polyunsaturated fatty acids, whose double-bond structures are susceptible to oxidative attack by reactive oxygen species, free radicals, or metal ions. Lipid peroxidation can proceed through initiation, propagation, and termination stages, ultimately forming various aldehydes, ketones, and peroxides. Among them, MDA is one of the most commonly used representative detection indicators.
(2) Structural characteristics
MDA is a small-molecule dialdehyde with relatively high reactivity. It can undergo addition or crosslinking reactions with proteins, nucleic acids, phospholipids, and amino compounds. Therefore, MDA is not only a product of lipid peroxidation, but may also participate in molecular modification processes associated with oxidative damage.
(3) Indicator significance
Increased MDA content usually indicates enhanced lipid peroxidation and is commonly observed in studies of oxidative stress, inflammation, ischemia-reperfusion injury, drug toxicity, heavy metal exposure, radiation injury, and cellular senescence. MDA is not the only oxidative stress indicator and should be analyzed together with SOD, GSH, GSH-Px, CAT, ROS levels, 4-HNE, or protein carbonylation.
1.2 Relationship with Oxidative Damage
(1) Membrane structural damage
Lipid peroxidation disrupts the fluidity, integrity, and permeability of cell membranes and organelle membranes. Increased MDA generation usually reflects elevated membrane lipid oxidation and may be accompanied by mitochondrial injury, ionic homeostasis disturbance, and activation of cell death signals.
(2) Protein and nucleic acid modification
MDA can react with amino acid residues such as lysine and arginine, and can also form adducts with DNA bases. These modifications may affect enzyme activity, receptor function, signal transduction, and genetic stability.
(3) Association with pathological processes
In studies of cardiovascular diseases, diabetes, neurodegenerative diseases, liver injury, kidney injury, tumor microenvironment, drug toxicity, and environmental pollutant exposure, MDA is often used as an auxiliary indicator for evaluating the degree of oxidative damage.
Table 1. Positioning of MDA Detection in Oxidative Stress Research
Observation Level | What MDA Reflects | Common Associated Indicators | Key Interpretation Points |
Membrane lipid oxidation | Accumulation of polyunsaturated fatty acid peroxidation products | 4-HNE, lipid peroxides, ROS | Reflects the degree of membrane lipid injury |
Antioxidant defense | Imbalance between oxidation products and antioxidant systems | SOD, CAT, GSH, GSH-Px | Should be analyzed together with antioxidant enzymes and reducing substances |
Tissue injury | Oxidative damage after inflammation, ischemia, or toxic stimulation | LDH, ALT, AST, inflammatory factors | Should be interpreted with histopathology and functional indicators |
Pharmacodynamic evaluation | Intervention effect of antioxidants or protective agents | ROS, GSH, inflammatory indicators | Decreased MDA usually suggests reduced lipid peroxidation |
2 Basic Principles of MDA Detection
2.1 TBA Reaction System
(1) Reaction basis
The most classic MDA detection method is the thiobarbituric acid method, also known as the TBA method. Under acidic and heated conditions, MDA reacts with thiobarbituric acid (TBA) to form a red MDA-TBA adduct. This product has a characteristic absorption peak in the visible-light region and can be used for colorimetric quantification.
(2) Concept of TBARS
The TBA method does not detect pure MDA exclusively. Instead, it detects thiobarbituric acid-reactive substances, commonly referred to as TBARS. In addition to MDA, some aldehydes, sugar degradation products, oxidized lipid fragments, and other reactive small molecules may also react with TBA. Therefore, the TBA colorimetric method is simple to operate but has limited specificity.
(3) Quantification method
The TBA method can calculate MDA content using a standard curve. The standard can be MDA itself or MDA-releasing precursors such as 1,1,3,3-tetraethoxypropane or 1,1,3,3-tetramethoxypropane. Results can be normalized by sample volume, protein content, tissue weight, or cell number.
2.2 Colorimetric and Fluorescence Detection
(1) Colorimetric detection
The MDA-TBA adduct is commonly detected by measuring absorbance near 532 nm. Some protocols use multi-wavelength correction at 450 nm, 532 nm, and 600 nm to reduce interference from sugars, protein precipitation, turbidity, and background absorbance.
(2) Fluorescence detection
The MDA-TBA adduct can also be detected by fluorescence, commonly using an excitation wavelength of approximately 515 nm and an emission wavelength of approximately 553 nm. Fluorescence detection is more sensitive than ordinary colorimetry and is suitable for samples with low MDA content, but it has higher requirements for instrument parameters, background fluorescence, and sample cleanliness.
(3) Method selection
Colorimetric detection is suitable for routine screening and experiments with large sample numbers. Fluorescence detection is suitable for low-content samples or studies requiring higher sensitivity. If higher specificity is required, separation-based detection methods such as HPLC, GC, or LC-MS should be preferred.
3 Common MDA Detection Methods
3.1 TBA Colorimetric Method
(1) Method characteristics
The TBA colorimetric method is relatively simple and low-cost. It is suitable for serum, plasma, tissue homogenates, cell lysates, and some culture supernatant samples. This method is suitable for comparing relative changes in lipid peroxidation levels among different treatment groups.
(2) Detection workflow
Samples are mixed with TBA reaction solution, acidic components, and protein precipitation components, then heated to form the MDA-TBA adduct. After cooling and centrifugation, the supernatant is measured near 532 nm, and content is calculated using a standard curve.
(3) Main limitations
The TBA colorimetric method is easily affected by non-MDA reactants. Strictly speaking, the result is more accurately expressed as TBARS level. If precise quantification of MDA itself is required, the TBA colorimetric method alone is not recommended.
3.2 TBA Fluorescence Method
(1) Method characteristics
The TBA fluorescence method detects the fluorescence signal of the MDA-TBA adduct and has higher sensitivity. It is suitable for systems with low MDA content or limited sample volume.
(2) Applicable samples
Cell samples, low-concentration serum samples, micro tissue samples, and models with relatively weak oxidative stress may use fluorescence detection to improve sensitivity.
(3) Precautions
Fluorescence detection requires low sample background. Hemoglobin, bilirubin, drug metabolites, culture medium components, or tissue autofluorescence may interfere with results. Sample blanks and reagent blanks should be included when necessary.
3.3 HPLC Method
(1) Method characteristics
In the HPLC method, MDA is usually reacted with TBA to form the MDA-TBA adduct, which is then separated chromatographically and quantified using a UV or fluorescence detector. This method can reduce interference from other TBARS components and improve specificity.
(2) Applicable scenarios
When sample matrices are complex, interferences are abundant, or accurate comparison of MDA levels is required, HPLC is more reliable than ordinary TBA colorimetry. It is more suitable for drug toxicology, clinical sample analysis, and high-quality mechanistic studies.
(3) Technical requirements
HPLC requires a chromatographic system, column, mobile-phase optimization, and standard calibration. Although the operation is more complex, it can significantly improve peak separation and quantitative reliability.
3.4 GC and LC-MS Methods
(1) GC method
GC usually requires derivatization of MDA before separation and detection by gas chromatography. This method has high sensitivity, but sample pretreatment is complex and has high requirements for derivatization efficiency and volatility.
(2) LC-MS method
LC-MS improves detection specificity through both mass-to-charge ratio and chromatographic retention time. It is suitable for precise quantification of MDA or MDA derivatives in complex samples. Stable isotope internal standards are usually required for absolute quantification.
(3) Application positioning
GC and LC-MS are more suitable for high-precision analysis, methodological research, and complex matrix validation. They are not the first choice for routine high-throughput MDA detection in general laboratories.
Table 2. Comparison of Common MDA Detection Methods
Method | Detection Target | Advantages | Limitations | Applicable Scenario |
TBA colorimetric method | MDA-TBA adduct / TBARS | Simple operation, low cost, relatively high throughput | Limited specificity, easily affected by interference | Routine oxidative stress research |
TBA fluorescence method | Fluorescence signal of MDA-TBA adduct | Higher sensitivity | Strongly affected by background fluorescence and sample matrix | Low-content samples, micro-detection |
HPLC method | Separated MDA-TBA adduct | Better specificity and more reliable quantification | Higher instrument and method requirements | Complex samples, high-quality quantification |
GC method | Derivatized MDA | High sensitivity and resolution | Complex pretreatment | Precise quantification, methodological research |
LC-MS method | MDA or MDA derivatives | High specificity, compatible with internal standards | High cost and demanding method development | High-precision quantification, complex matrix analysis |
4 Experimental Workflow of the TBA Colorimetric Method
4.1 Sample Preparation
(1) Serum and plasma
Serum or plasma samples should avoid severe hemolysis. Red blood cell rupture releases hemoglobin and iron ions, which may promote ex vivo lipid oxidation and interfere with colorimetric readings. Samples should be centrifuged and separated as soon as possible after collection and stored at low temperature.
(2) Tissue homogenates
Tissue samples are usually homogenized by adding pre-cooled buffer at a defined weight-to-volume ratio. Homogenization should be performed at low temperature to reduce ex vivo oxidation. After centrifugation, the supernatant is used for detection, and protein concentration is measured simultaneously for result normalization.
(3) Cell samples
Adherent or suspension cells can be washed with PBS and then lysed or homogenized. When sample amount is limited, lysis efficiency and protein recovery should be considered. Different treatment groups should use the same cell number, lysis volume, and centrifugation conditions.
4.2 Establishment of the Reaction System
(1) Acidic conditions
The reaction between MDA and TBA usually requires an acidic environment. Trichloroacetic acid, acetic acid, hydrochloric acid, or other acidic components are commonly used to provide reaction conditions and promote protein precipitation, reducing interference from proteins in color development and absorbance readings.
(2) TBA reaction solution
TBA is the core reagent in the chromogenic reaction. Its concentration, pH, dissolution state, and freshness affect reaction efficiency. Long-term storage of TBA solution may affect background and sensitivity, so it should be stored and used according to the kit or experimental protocol.
(3) Antioxidant protection
During sample pretreatment, antioxidants such as BHT may be added depending on experimental needs to reduce continuing lipid peroxidation during processing. Whether antioxidants are added should be kept consistent among groups to avoid affecting comparison results.
4.3 Heating Reaction and Detection
(1) Heating reaction
After samples are mixed with reaction solution, they are usually reacted in a boiling water bath or under high-temperature conditions for a defined time to allow MDA and TBA to fully form the chromogenic product. Insufficient temperature leads to incomplete reaction, while excessively long reaction time may enhance nonspecific reactions.
(2) Cooling and centrifugation
After the reaction ends, samples should be cooled rapidly and centrifuged to remove protein precipitates and insoluble impurities. If the supernatant is turbid, direct reading should be avoided because scattering background may increase.
(3) Absorbance measurement
Measure the absorbance of the clarified supernatant near 532 nm. If multi-wavelength correction is used, background absorbance should be subtracted according to the kit instructions or established formula.
4.4 Result Calculation
(1) Standard curve method
Establish a standard curve using MDA standard or MDA precursor standard, and calculate sample MDA concentration according to absorbance or fluorescence intensity. The standard curve should cover the sample concentration range to avoid extrapolated calculation.
(2) Protein normalization
Tissue and cell samples are often expressed as nmol/mg protein. In this case, sample protein concentration must be measured simultaneously, and the protein assay method should not be affected by TCA, TBA, or sample lysis buffer.
(3) Volume or weight normalization
Serum, plasma, and culture supernatant are often expressed as nmol/mL. Tissue samples may also be expressed as nmol/g tissue. When comparing across experiments, the normalization method should be consistent.
5 Sample Types and Pretreatment Points
5.1 Serum and Plasma Samples
MDA detection in serum and plasma is suitable for evaluating systemic oxidative stress status, but it is easily affected by diet, hemolysis, blood collection conditions, storage time, and freeze-thaw cycles. For intergroup comparison, blood collection time, anticoagulation method, centrifugation conditions, and storage temperature should be standardized.
5.2 Tissue Samples
Tissue MDA detection is commonly used in oxidative injury studies of liver, kidney, brain, myocardium, lung, intestine, and tumor tissues. Different tissues vary greatly in lipid content, residual blood, and endogenous pigments. Pretreatment conditions should be optimized according to tissue type. Brain and liver tissues have relatively high lipid peroxidation background, so low-temperature homogenization and detection timing require particular control.
5.3 Cell Samples
Cellular MDA detection is suitable for evaluating the effects of drugs, toxicants, hypoxia-reoxygenation, inflammatory stimulation, oxidant treatment, and antioxidant intervention. MDA content in cell samples is usually low, so sufficient cell amount should be ensured. Results should be interpreted together with protein concentration, cell viability, and cell death ratio.
5.4 Plant and Environmental Biological Samples
Plant leaves, roots, algae, and aquatic animal tissues are also commonly used for MDA detection to evaluate membrane lipid peroxidation caused by salt stress, drought, heavy metals, pesticides, low temperature, high temperature, and pollutant exposure. These samples often contain abundant pigments, phenolics, and reducing substances. Corrected absorbance or HPLC should be used when necessary to improve reliability.
Table 3. Pretreatment Focus for MDA Detection in Different Samples
Sample Type | Main Concern | Recommended Normalization Method | Common Interferences |
Serum/plasma | Avoid hemolysis; control freeze-thaw cycles | nmol/mL | Hemoglobin, bilirubin, lipemia |
Tissue homogenate | Low-temperature homogenization; remove insoluble materials | nmol/mg protein or nmol/g tissue | Blood residue, pigments, lipid background |
Cell lysate | Ensure consistent cell amount and lysis | nmol/mg protein or nmol/10⁶ cells | Cell death ratio, culture medium residues |
Culture supernatant | Low-concentration detection; background subtraction | nmol/mL | Culture medium components, serum additives |
Plant sample | Remove pigment interference; control continued oxidation | nmol/g fresh weight or nmol/mg protein | Chlorophyll, phenolics, reducing substances |
6 Result Interpretation and Common Problems
6.1 Interpretation of Increased MDA
(1) Enhanced lipid peroxidation
Increased MDA usually indicates enhanced lipid peroxidation and is commonly associated with ROS accumulation, decreased antioxidant capacity, mitochondrial injury, inflammatory activation, or membrane structural disruption.
(2) Aggravated oxidative damage
In tissue or cell injury models, increased MDA often coexists with cell membrane injury, protein oxidation, inflammatory response, and functional impairment. If MDA decreases after antioxidant intervention, this may indicate reduced lipid peroxidation.
(3) Not sufficient for independent disease characterization
MDA is not a specific marker of disease or toxicity. Oxidative stress caused by different mechanisms can increase MDA, so results must be interpreted together with model background, treatment conditions, and other indicators.
6.2 False Elevation
(1) Oxidation during sample processing
If sampling, homogenization, heating, or storage is not controlled at low temperature, sample lipids may continue to oxidize, leading to falsely elevated MDA values.
(2) Reaction of non-MDA substances
TBA can react with various aldehydes, sugar degradation products, and oxidation products, causing TBARS results to be overestimated. This issue is especially obvious in complex samples.
(3) Turbidity and color interference
Incomplete protein precipitation, residual tissue pigments, lipemia, or sample turbidity can affect absorbance readings, causing elevated results or poor reproducibility.
6.3 False Decrease
(1) Incomplete reaction
Insufficient acidity, inadequate heating time, insufficient TBA concentration, or unstable reaction temperature can all lead to insufficient formation of the MDA-TBA adduct.
(2) Insufficient sample amount
Too few cells, too dilute tissue homogenate, or too low protein concentration may cause MDA levels to fall below the detection range.
(3) Abnormal standard curve
Incomplete hydrolysis of the standard, preparation errors, or an inappropriate standard curve linear range can lead to falsely low or highly biased sample calculations.
Table 4. Common Problems and Control Directions in MDA Detection
Problem | Possible Cause | Effect on Result | Control Direction |
High blank value | High TBA reagent background, contaminated reaction solution | Reduced sensitivity | Replace reagents and set reagent blanks |
High sample reading | Ex vivo oxidation, nonspecific TBARS, turbidity | Overestimation of MDA level | Process at low temperature, centrifuge thoroughly, use HPLC if necessary |
Poor reproducibility | Inconsistent heating time, uneven sampling | Increased within-group variation | Standardize reaction time and operation rhythm |
Yellow or turbid color | Incomplete protein precipitation, high lipid background | Absorbance deviation | Strengthen centrifugation and optimize precipitation step |
Nonlinear standard curve | Standard preparation error or inappropriate concentration range | Unreliable calculation | Reprepare standards and adjust concentration range |
Low result | Incomplete reaction, insufficient sample amount | Underestimation of lipid peroxidation | Optimize reaction conditions and increase sample concentration |
7 Application Directions of MDA Detection
7.1 Oxidative Stress Mechanism Research
MDA detection is commonly used in studies of free radical injury, mitochondrial dysfunction, inflammatory stimulation, hypoxia-reoxygenation, radiation injury, and cellular senescence. Changes in MDA content can reflect the degree of membrane lipid oxidation and are one of the basic indicators in oxidative stress research.
7.2 Pharmacology and Antioxidant Evaluation
In studies of antioxidants, natural products, drug protective effects, and drug toxicity, MDA is commonly used to evaluate whether an intervention reduces lipid peroxidation. If MDA decreases in the treatment group while SOD, GSH, GSH-Px, or CAT recovers, this usually supports an antioxidant protective effect.
7.3 Toxicology Research
Drugs, pesticides, heavy metals, nanomaterials, environmental pollutants, and industrial chemicals can all induce oxidative stress. MDA detection can be used to evaluate the degree of membrane lipid injury caused by test substances and should be combined with histopathology, inflammatory factors, and functional indicators to determine toxicity mechanisms.
7.4 Clinical and Disease-Related Research
MDA can be used in studies of oxidative stress associated with cardiovascular diseases, diabetic complications, liver diseases, kidney diseases, neurodegenerative diseases, and tumors. It should be noted that MDA is more suitable as a research indicator or auxiliary indicator and should not be used alone as a diagnostic basis for disease.
8 Reagent and Product Selection Related to MDA Detection
Table 5. Basic Reagents for MDA Detection and Combined Oxidative Stress Analysis
Product Type | Product Name | CAS No. | Applicable Research Direction / Use |
Detection target / standard | Malondialdehyde (MDA) | Used as an MDA standard, for methodological validation, or lipid peroxidation marker research | |
Chromogenic substrate | Thiobarbituric Acid (TBA) | Used for MDA detection by the TBA or TBARS method | |
Protein precipitation / acidic reaction system | Trichloroacetic Acid (TCA) | Used for protein precipitation, acidic color development reactions, and sample pretreatment | |
Acidic reaction system | Glacial Acetic Acid | Used to establish the acidic environment for the TBA reaction or prepare related reaction solutions | |
MDA standard precursor | 1,1,3,3-Tetraethoxypropane | Can be hydrolyzed to generate MDA and used to establish standard curves | |
MDA standard precursor | 1,1,3,3-Tetramethoxypropane | Can be used as an MDA standard precursor for methodological validation and standard curve preparation | |
Sample oxidation inhibition | 2,6-Di-tert-butyl-4-methylphenol (BHT) | Inhibits continued oxidation during sample processing and is suitable for lipid sample pretreatment | |
Metal ion chelation | Disodium EDTA Dihydrate | Chelates metal ions and reduces the effect of metal-catalyzed oxidation on MDA results | |
Extraction / background control | n-Butanol | Used in some TBARS methods to extract MDA-TBA adducts and reduce aqueous-phase background interference | |
Extraction / background control | Pyridine | Can be combined with n-butanol to form an extraction system for some MDA-TBA detection methods | |
ROS detection | DCFH-DA | Used for intracellular ROS detection and combined evaluation of oxidative stress with MDA | |
Lipid peroxidation co-indicator | 4-Hydroxynonenal (4-HNE) | Used together with MDA as an aldehyde-product indicator of lipid peroxidation | |
Glutathione system | Reduced Glutathione (GSH) | Used in glutathione antioxidant system research and combined with MDA to analyze reducing buffer capacity | |
Glutathione system | Oxidized Glutathione (GSSG) | Used for GSH/GSSG ratio analysis to evaluate redox status | |
Oxidative stress model induction | tert-Butyl Hydroperoxide (t-BHP) | Commonly used to induce lipid peroxidation and oxidative stress injury models | |
Cell viability evaluation | WST-8 | Used in CCK-8-type cell viability assays to help determine the degree of cell injury corresponding to MDA elevation | |
Cell viability evaluation | MTT | Used for cell metabolic activity assays to help evaluate oxidative injury intensity | |
Protein standard | Bovine Serum Albumin (BSA) | Used for BCA or Bradford protein quantification standard curves and MDA normalization by protein concentration |
Table 6. Ready-to-Use Products Related to MDA Detection and Combined Oxidative Stress Evaluation
Product Category | Cat. No. | Product Name | Grade / Specification | Role in the System | Applicable Direction |
MDA content detection | Malondialdehyde (MDA) Content Assay Kit (TBA, Colorimetric Method) | BioReagent | Based on the reaction between MDA and TBA to generate a chromogenic product; absorbance reflects MDA/TBARS levels | Routine MDA detection in serum, plasma, tissue homogenates, and cell lysates | |
MDA content detection | Malondialdehyde (MDA) Content Assay Kit (TBA, Fluorometric Method) | BioReagent | Detects fluorescence signal of the MDA-TBA adduct and improves sensitivity for low-content samples | Low-MDA samples, micro cell samples, micro tissue samples | |
MDA / Lipid Peroxidation Assay | Lipid Peroxidation (MDA) Assay Kit | sufficient for 100colorimetricorfluorometrictests | Used to determine MDA/TBARS levels associated with lipid peroxidation; supports colorimetric or fluorometric readout | Evaluation of lipid peroxidation levels, oxidative stress model analysis, and MDA determination in cell or tissue samples | |
MDA immunodetection | Malondialdehyde (MDA) ELISA Kit | BioReagent | Detects MDA-related levels through an ELISA system | Quantification of MDA levels in biological samples and oxidative injury evaluation | |
MDA immunodetection | Rat Malondialdehyde(MDA) ELISA Kit | BioReagent | MDA ELISA detection system for rat samples | Rat oxidative stress models, pharmacology, and toxicology studies | |
Plant MDA detection | Plant Malondialdehyde (MDA) Content Assay Kit (TBA, Colorimetric Method) | BioReagent | TBA colorimetric detection system designed for plant samples | Plant stress studies, including salt stress, drought, heavy metals, and pollutant exposure | |
Protein normalization | BCA Protein Assay Kit |
| Measures protein concentration in tissue or cell samples | Normalizes MDA results as nmol/mg protein | |
Protein normalization | Ready-to-use BCA Protein Assay Kit | BioReagent, for protein analysis, ready-to-use | Ready-to-use BCA system that reduces reagent preparation steps | Protein normalization after MDA detection in tissue homogenates and cell lysates | |
Protein normalization | Ready-to-use BCA Protein Assay Kit (Stable Version) | BioReagent,for protein analysis | Stable BCA protein quantification system | Multi-batch sample detection and MDA result standardization | |
Protein normalization | Bradford Assay Solution (Ready-to-use) [for Protein determination] |
| Measures protein concentration based on Coomassie Brilliant Blue binding | Rapid protein quantification and MDA correction by protein content | |
Protein normalization | Bradford Protein Assay Kit | BioReagent, for protein analysis | Protein concentration determination by Bradford method | Protein normalization for tissue and cell samples | |
Protein normalization | Ready-to-use Bradford Protein Assay Kit | BioReagent,for protein analysis,ready-to-use | Ready-to-use Bradford system | Rapid high-throughput protein determination | |
Protein normalization | Ready-to-use Bradford Protein Assay Kit (Detergent Compatible) | BioReagent,for protein analysis,ready-to-use | Improves compatibility for protein determination in detergent-containing lysates | Protein normalization for cell samples and tissue lysates containing lysis reagents | |
Lipid peroxidation co-indicator | 4-Hydroxynonenal (4-HNE) ELISA Kit | BioReagent | Detects 4-HNE level as a lipid peroxidation-related aldehyde indicator | Combined with MDA to evaluate membrane lipid oxidative damage | |
Lipid peroxidation co-indicator | Human 4-Hydroxynonenal (4-HNE) ELISA Kit | BioReagent | Detects 4-HNE in human samples | Oxidative injury research in human serum, plasma, cells, or tissues | |
Lipid peroxidation co-indicator | Mouse 4-Hydroxynonenal (4-HNE) ELISA Kit | BioReagent | Detects 4-HNE in mouse samples | Mouse oxidative stress, inflammation, and toxicology models | |
Antioxidant defense co-indicator | Total Superoxide Dismutase (SOD) Assay Kit (NBT Riboflavin Microplate Method) | BioReagent | Detects total SOD activity and reflects superoxide anion scavenging capacity | Combined with MDA to evaluate the balance between oxidative injury and antioxidant defense | |
Antioxidant defense co-indicator | Total Superoxide Dismutase (SOD) Assay Kit (NBT Riboflavin Colorimetric Method) | BioReagent | Colorimetric detection of total SOD activity | Routine spectrophotometer platforms and antioxidant evaluation in tissue and cell samples | |
Antioxidant defense co-indicator | Total Superoxide Dismutase (T-SOD) Activity Assay Kit (WST-8, Micro Method) | BioReagent | Detects SOD activity based on the WST-8 system | Micro-samples, microplate detection, and combined analysis with MDA | |
Antioxidant defense co-indicator | Catalase (CAT) Activity Assay Kit (UV Micro Method) | BioReagent | Detects the ability of CAT to decompose H₂O₂ | Combined with MDA and SOD to evaluate the oxidative stress chain | |
Antioxidant defense co-indicator | Catalase (CAT) Activity Assay Kit (UV Colorimetric Method) | BioReagent | Detects CAT activity by UV colorimetry | Antioxidant enzyme detection in routine tissue, cell, and serum samples | |
Antioxidant defense co-indicator | Catalase (CAT) Activity Assay Kit (AHM, Micro Method) | BioReagent | Detects CAT activity based on the ammonium molybdate system | CAT detection in micro-samples and combined use with MDA results | |
Antioxidant defense co-indicator | Catalase (CAT) Activity Assay Kit (AHM, Colorimetric Method) | BioReagent | Colorimetric detection of CAT activity | Routine antioxidant defense evaluation | |
Antioxidant defense co-indicator | Glutathione Peroxidase (GSH-Px) Activity Assay Kit (DTNB, Micro Method) | BioReagent | Detects GSH-Px activity and reflects peroxide reduction capacity | Combined with MDA to evaluate lipid peroxidation and glutathione system status | |
Antioxidant defense co-indicator | Glutathione Peroxidase (GSH-Px) Activity Assay Kit (DTNB, Colorimetric Method) | BioReagent | Colorimetric detection of GSH-Px activity | Antioxidant enzyme activity detection in tissue, cell, and serum samples | |
Sample processing buffer | PBS (pH 7.4, Sterile) | BioReagent,Low Endotoxin,sterile-filtered,for cell culture | Maintains an isotonic environment during sample processing and cell washing | Cell washing, sample dilution, and processing before cellular MDA detection | |
Sample processing buffer | PBS, DNase&RNase Free | sterile-filtered, BioReagent, DNase, RNase free, ready-to-use, for cell culture, 1× | Provides a nuclease-free PBS system | Cell sample processing and compatibility with downstream nucleic acid-related experiments | |
Sample processing buffer | PhosphateBuffered Saline(PBS)1X concentrate | 1X,Sterile,pH7.2-7.4 | Routine isotonic buffer system | Cell washing, sample dilution, and support for tissue processing |
MDA content detection provides an important reference for lipid peroxidation and oxidative stress research. In practical experiments, the TBA colorimetric method, fluorescence method, or chromatographic methods should be selected according to sample type, sensitivity requirements, and specificity needs. Standardized pretreatment, standard curves, and normalization strategies can improve result reliability.
For more related articles, please see below:
[1] Determination of malondialdehyde in plant tissue species
